Fig. 1From: Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patientsOPTIMIZE study design. TMP = tacrolimus, mycophenolate mofetil, prednisolon, TAC = tacrolimus, CsA = cyclosporine A, BAX = basiliximab, RND = randomization, TEP = tacrolimus, everolimus, prednisolone, EVR = everolimusBack to article page